Bortezomib and obatoclax for dual blockade of protein degradation pathways show synergistic anti-tumor effect in human acute T lymphoblastic leukemia cells

ZHOU Dan; DAI Lixia; LIU Xiaolian; QUE Fuchang; XU Yuyan; LUO Xin; ZHU Yaolu; LIU Shuwen; LI Yilei; YU Le

doi:10.12122/j.issn.1673-4254.2019.04.04

Home>Articles>Bortezomib and obatoclax for dual blockade of protein degradation pathways show synergistic anti-tumor effect in human acute T lymphoblastic leukemia cells

DOI: 10.12122/j.issn.1673-4254.2019.04.04

Bortezomib and obatoclax for dual blockade of protein degradation pathways show synergistic anti-tumor effect in human acute T lymphoblastic leukemia cells

ZHOU Dan

DAI Lixia

LIU Xiaolian

QUE Fuchang

XU Yuyan

LUO Xin

ZHU Yaolu

LIU Shuwen

LI Yilei

YU Le

Machine-generated Keywords：

Publication Date：2019-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：8( 401-408 )

Journal of Southern Medical University

PKUISTIC

ISSN：1673-4254

Year, Vol.(Issue)：2019,39(4)